Agenus Market Cap

Agenus has a market cap or net worth of $149.37 million as of April 28, 2026. Its market cap has increased by 264.32% in one year.

Market Cap

149.37M

Enterprise Value

205.36M

1-Year Change

264.32%

Ranking

#4035

Market Cap Chart

Since February 8, 2000, Agenus's market cap has decreased from $1.10B to $149.37M, a decrease of -86.38%. That is a compound annual growth rate of -7.32%.

Market Cap History

Date	Market Cap	% Change
Apr 27, 2026	157.00M	47.00%
Dec 31, 2025	106.80M	66.10%
Dec 31, 2024	64.30M	-79.64%
Dec 29, 2023	315.80M	-56.83%
Dec 30, 2022	731.50M	-11.55%
Dec 31, 2021	827.00M	36.76%
Dec 31, 2020	604.70M	8.16%
Dec 31, 2019	559.10M	95.76%
Dec 31, 2018	285.60M	-12.55%
Dec 29, 2017	326.60M	-9.03%
Dec 30, 2016	359.00M	-6.58%
Dec 31, 2015	384.30M	54.40%
Dec 31, 2014	248.90M	165.92%
Dec 31, 2013	93.60M	-7.14%
Dec 31, 2012	100.80M	134.97%
Dec 30, 2011	42.90M	-57.23%
Dec 31, 2010	100.30M	74.74%
Dec 31, 2009	57.40M	80.50%
Dec 31, 2008	31.80M	-67.22%
Dec 31, 2007	97.00M	15.61%
Dec 29, 2006	83.90M	-61.34%
Dec 30, 2005	217.00M	-52.90%
Dec 31, 2004	460.70M	2.90%
Dec 31, 2003	447.70M	32.18%
Dec 31, 2002	338.70M	-28.80%

View and export this data all the way back to 2000. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AN2 Therapeutics	156.22M
Oramed Pharmaceuticals	155.72M
Molecular Partners AG	155.64M
Humacyte	155.41M
Fate Therapeutics	154.63M
Galectin Therapeutics	153.38M
Alps Group	149.76M
TuHURA Biosciences	149.41M

Market Cap Rankings